SHM Sends Letter to House Ways and Means Committee on Opioids
SHM submitted comments to the Ways and Means Committee and subcommittee on health regarding the opioid epidemic.
SHM Provides Feedback to Senate Finance Committee on Opioid Policies
SHM responds to the Senate Finance Committee request for feedback on policies to address the opioid epidemic.
SHM Submits Comments to CMS on OPPS Proposed Rule
SHM submitted comments regarding the pain management questions in the HCAHPS survey to Medicare in the Outpatient Prospective Payment System (OPPS) proposed rule.
SHM Signs onto Letter to Congressional Leaders Regarding the Prescription Drug Monitoring Programs (PDMPs)
We write to you as leading participants in the prescription drug supply chain – i.e., manufacturers, distributors, payers, physicians, pharmacies, testing laboratories, treatment providers – as well as patient groups, business leaders, and other expert parties, to urge the full support of Congress (and state legislatures) of the continued expansion and deployment of robust and interoperable Prescription Drug Monitoring Programs (PDMPs) in each of the 50 states.
SHM Signs on to Letter Supporting Antibiotic Stewardship Requirements for LTCFs
Along with other organizations, SHM signs onto a letter to CMS supporting antibiotic stewardship requirements for long term care facilities (LTCFs) in order to participate in Medicare programs.